|
Name |
1,8-Dihydroxy-3-methoxy-6-methylxanthone
|
| Molecular Formula | C15H12O5 | |
| IUPAC Name* |
1,8-dihydroxy-3-methoxy-6-methylxanthen-9-one
|
|
| SMILES |
CC1=CC(=C2C(=C1)OC3=CC(=CC(=C3C2=O)O)OC)O
|
|
| InChI |
InChI=1S/C15H12O5/c1-7-3-9(16)13-11(4-7)20-12-6-8(19-2)5-10(17)14(12)15(13)18/h3-6,16-17H,1-2H3
|
|
| InChIKey |
QQWCJIAJCYGAIK-UHFFFAOYSA-N
|
|
| Synonyms |
1,8-dihydroxy-3-methoxy-6-methylxanthone; 1,8-dihydroxy-3-methoxy-6-methyl-9H-xanthen-9-one; CHEBI:68287; DTXSID101234603; 1,8-dihydroxy-3-methoxy-6-methylxanthen-9-one; 1,8-Dihydroxy-3-methoxy-6-methyl-9H-xanthene-9-one; Q27136781; 1043624-67-4
|
|
| CAS | 1043624-67-4 | |
| PubChem CID | 25034673 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 272.25 | ALogp: | 3.1 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 20 | QED Weighted: | 0.663 |
| Caco-2 Permeability: | -4.91 | MDCK Permeability: | 0.00000891 |
| Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.945 |
| Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.006 |
| 30% Bioavailability (F30%): | 0.864 |
| Blood-Brain-Barrier Penetration (BBB): | 0.013 | Plasma Protein Binding (PPB): | 92.06% |
| Volume Distribution (VD): | 0.696 | Fu: | 8.52% |
| CYP1A2-inhibitor: | 0.978 | CYP1A2-substrate: | 0.946 |
| CYP2C19-inhibitor: | 0.516 | CYP2C19-substrate: | 0.088 |
| CYP2C9-inhibitor: | 0.721 | CYP2C9-substrate: | 0.924 |
| CYP2D6-inhibitor: | 0.745 | CYP2D6-substrate: | 0.868 |
| CYP3A4-inhibitor: | 0.271 | CYP3A4-substrate: | 0.154 |
| Clearance (CL): | 3.411 | Half-life (T1/2): | 0.568 |
| hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.069 |
| Drug-inuced Liver Injury (DILI): | 0.923 | AMES Toxicity: | 0.553 |
| Rat Oral Acute Toxicity: | 0.098 | Maximum Recommended Daily Dose: | 0.863 |
| Skin Sensitization: | 0.881 | Carcinogencity: | 0.032 |
| Eye Corrosion: | 0.429 | Eye Irritation: | 0.98 |
| Respiratory Toxicity: | 0.393 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001750 | ![]() |
0.774 | D0K8KX | ![]() |
0.386 | ||
| ENC003136 | ![]() |
0.710 | D04AIT | ![]() |
0.378 | ||
| ENC002462 | ![]() |
0.667 | D06GCK | ![]() |
0.363 | ||
| ENC005647 | ![]() |
0.647 | D07MGA | ![]() |
0.318 | ||
| ENC001749 | ![]() |
0.620 | D0G4KG | ![]() |
0.271 | ||
| ENC001653 | ![]() |
0.594 | D0FA2O | ![]() |
0.259 | ||
| ENC004846 | ![]() |
0.594 | D0G5UB | ![]() |
0.250 | ||
| ENC005808 | ![]() |
0.594 | D0S5CH | ![]() |
0.250 | ||
| ENC005191 | ![]() |
0.594 | D0AZ8C | ![]() |
0.244 | ||
| ENC006013 | ![]() |
0.592 | D04UTT | ![]() |
0.243 | ||